Dabigatran was similarly effective as standard of care (SOC) in resolving thrombus and preventing recurrent venous thromboembolism (VTE), without raising the risk of bleeding in children, according to the DIVERSITY trial presented at ASH 2020 — thus providing a potential oral alternative to standard of care for the paediatric population.
Kids with Crohn’s disease may do well to start treatment on infliximab, which has proven to be superior to conventional regimens such as corticosteroids or exclusive enteral nutrition (EEN) in terms of short-term clinical and endoscopic remission, according to the results of an open-label trial.
Children born to lower-income households tend to be poorly prepared for school, according to a recent Singapore study. In these households, too, the burden of depressive and anxiety symptoms among mothers appears to be high, which in turn contributes to the gap in school readiness.
High doses of parenteral lipids during the first week of life eases aggressive weight loss among very low birthweight (VLBW) infants, a new study has found. This feeding regimen may also protect against extra-uterine growth restrictions.
Musculoskeletal pain at the upper back, neck, and wrists/hands is more common in young people who use smartphones, and particularly so in those who are addicted to their devices, according to a new study.
Antenatal use of dexamethasonesignificantly reduces the risk of neonatal death and stillbirth among women at risk of early preterm birth in low-resource countries, according to the WHO ACTION-I* study.
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa,
08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.